Molecular Endocrinology, Vol 10, 1138-1146, Copyright © 1996 by Endocrine Society

ARTICLES

GRK2 and beta-arrestin 1 as negative regulators of thyrotropin receptor- stimulated response

L Iacovelli, R Franchetti, M Masini and A De Blasi
Consorzio Mario Negri Sud, Istituto di Ricerche Farmacologiche Mario Negri, Santa Maria Imbaro, Italy.

Arrestins are regulatory proteins for a number of G-coupled receptors. The binding of arrestin to receptor phosphorylated by G protein-coupled receptor kinase (GRK) quenches the activation of the G protein, thus resulting in receptor homologous desensitization. We have previously shown that the levels of beta-arrestin1 are regulated by intracellular cAMP and proposed that this may represent one homeostatic mechanism with which to regulate some cellular responses. To test this hypothesis, we focused on the TSH receptor using a rat thyroid cell line, FRTL5. We found that beta-arrestin1 is the only detectable isoform of arrestin expressed in FRTL5 and that its expression is regulated by TSH. To investigate the possible role of GRK2/beta- arrestin1 machinery in the mechanism of TSH receptor homologous desensitization, we used a cotransfection approach. The TSH-induced cAMP accumulation in COS7 cells transfected with TSH receptor was reduced by 35-45% when cotransfected with GRK2 and/or beta-arrestin1, indicating that the TSH receptor can be regulated by a GRK/arrestin mechanism. This raised the hypothesis that TSH increases the levels of beta-arrestin1, which in turn could regulate the TSH stimulation. To test this point a FRTL5-derived cell line overexpressing beta-arrestin1 was generated. In these cells the TSH-stimulated cAMP accumulation and, more importantly, the mitogenic activity were substantially blunted. Our results show that TSH receptor-stimulated cAMP accumulation and cell proliferation can be controlled by a GRK2/beta-arrestin1 mechanism.

This article has been cited by other articles:

				T. Metaye, P. Levillain, J.-L. Kraimps, and R. Perdrisot Immunohistochemical detection, regulation and antiproliferative function of G-protein-coupled receptor kinase 2 in thyroid carcinomas J. Endocrinol., July 1, 2008; 198(1): 101 - 110. [Abstract] [Full Text] [PDF]

				R. Frenzel, C. Voigt, and R. Paschke The Human Thyrotropin Receptor Is Predominantly Internalized by {beta}-Arrestin 2 Endocrinology, June 1, 2006; 147(6): 3114 - 3122. [Abstract] [Full Text] [PDF]

				L. Iacovelli, L. Capobianco, M. Iula, V. Di Giorgi Gerevini, A. Picascia, J. Blahos, D. Melchiorri, F. Nicoletti, and A. De Blasi Regulation of mGlu4 Metabotropic Glutamate Receptor Signaling by Type-2 G-Protein Coupled Receptor Kinase (GRK2) Mol. Pharmacol., May 1, 2004; 65(5): 1103 - 1110. [Abstract] [Full Text]

				T. Metaye, E. Menet, J. Guilhot, and J.-L. Kraimps Expression and Activity of G Protein-Coupled Receptor Kinases in Differentiated Thyroid Carcinoma J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3279 - 3286. [Abstract] [Full Text] [PDF]

				S. Mukherjee, V. V. Gurevich, A. Preninger, H. E. Hamm, M.-F. Bader, A. T. Fazleabas, L. Birnbaumer, and M. Hunzicker-Dunn Aspartic Acid 564 in the Third Cytoplasmic Loop of the Luteinizing Hormone/Choriogonadotropin Receptor Is Crucial for Phosphorylation-independent Interaction with Arrestin2 J. Biol. Chem., May 10, 2002; 277(20): 17916 - 17927. [Abstract] [Full Text] [PDF]

				L. Iacovelli, L. Capobianco, L. Salvatore, M. Sallese, G. M. D'Ancona, and A. De Blasi Thyrotropin Activates Mitogen-Activated Protein Kinase Pathway in FRTL-5 by a cAMP-Dependent Protein Kinase A-Independent Mechanism Mol. Pharmacol., November 1, 2001; 60(5): 924 - 933. [Abstract] [Full Text] [PDF]

				K. Krohn and R. Paschke Progress in Understanding the Etiology of Thyroid Autonomy J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3336 - 3345. [Full Text] [PDF]

				M. Sallese, S. Mariggiò, E. D'Urbano, L. Iacovelli, and A. De Blasi Selective Regulation of Gq Signaling by G Protein-Coupled Receptor Kinase 2: Direct Interaction of Kinase N Terminus with Activated Galpha q Mol. Pharmacol., April 1, 2000; 57(4): 826 - 831. [Abstract] [Full Text]

				C. Troispoux, F. Guillou, J.-M. Elalouf, D. Firsov, L. Iacovelli, A. De Blasi, Y. Combarnous, and E. Reiter Involvement of G Protein-Coupled Receptor Kinases and Arrestins in Desensitization to Follicle-Stimulating Hormone Action Mol. Endocrinol., September 1, 1999; 13(9): 1599 - 1614. [Abstract] [Full Text]

				L. Iacovelli, R. Franchetti, D. Grisolia, and A. De Blasi Selective Regulation of G Protein-Coupled Receptor-Mediated Signaling by G Protein-Coupled Receptor Kinase 2 in FRTL-5 Cells: Analysis of Thyrotropin, alpha 1B-Adrenergic, and A1 Adenosine Receptor-Mediated Responses Mol. Pharmacol., August 1, 1999; 56(2): 316 - 324. [Abstract] [Full Text]

				M. d. F. M. Lazari, X. Liu, K. Nakamura, J. L. Benovic, and M. Ascoli Role of G Protein-Coupled Receptor Kinases on the Agonist-Induced Phosphorylation and Internalization of the Follitropin Receptor Mol. Endocrinol., June 1, 1999; 13(6): 866 - 878. [Abstract] [Full Text]

				J. Zhang, S. S. G. Ferguson, L. S. Barak, S. R. Bodduluri, S. A. Laporte, P.-Y. Law, and M. G. Caron Role for G protein-coupled receptor kinase in agonist-specific regulation of µ-opioid receptor responsiveness PNAS, June 9, 1998; 95(12): 7157 - 7162. [Abstract] [Full Text] [PDF]

				T. T. Chuang, L. Paolucci, and A. De Blasi Inhibition of G Protein-coupled Receptor Kinase Subtypes by Ca2+/Calmodulin J. Biol. Chem., November 8, 1996; 271(45): 28691 - 28696. [Abstract] [Full Text] [PDF]

				R. B. Penn, R. M. Pascual, Y.-M. Kim, S. J. Mundell, V. P. Krymskaya, R. A. Panettieri Jr., and J. L. Benovic Arrestin Specificity for G Protein-coupled Receptors in Human Airway Smooth Muscle J. Biol. Chem., August 24, 2001; 276(35): 32648 - 32656. [Abstract] [Full Text] [PDF]